Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract
A systematic review and meta-analysis of 29 randomized controlled trials (2396 participants) across five types of arthritis (ankylosing spondylitis, rheumatoid arthritis, osteoarthritis, juvenile idiopathic arthritis and gout/hyperuricemia). Curcumin and Curcuma longa extract (120-1500 mg, 4-36 weeks) were safe and improved the severity of inflammation and pain in arthritis patients.
Referenced for these plants
How to cite
Zeng, L., Yang, T., Yang, K., Yu, G. et al (2022) 'Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Frontiers in Immunology, 13, pp. 891822. doi:10.3389/fimmu.2022.891822
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.